The long-term outlook for Lupin ₹765) remains negative. However, in the short term, the pharma stock is expected to remain resilient. The stock finds
from Business Line - Home http://bit.ly/2EyGu8S
via IFTTT
Monday, May 27, 2019
Subscribe to:
Post Comments (Atom)
Posts
Hello, my name isjamsheer. I'm a 22 year old .
No comments:
Post a Comment